Virtual Panel · August 5, 2026

Peptides and the Changing Gray Market

Dr. Martha Rumore joins the Endpoints News Manufacturing Day 2026 panel on peptide compounding, sourcing, and enforcement

Date: Wednesday, August 5, 2026
Time: 10:30 – 10:55 AM ET
Format: Virtual panel · free registration · hosted by Endpoints News
HLA Panelist: Dr. Martha Rumore, PharmD, JD, MS, LLM, FAPhA — Of Counsel, pharmacist-attorney and registered patent attorney, 200+ publications in FDA, DEA, and pharmacy law

Registration is handled by Endpoints News on their site. It is free.

Dr. Martha Rumore, Of Counsel, Health Law Alliance

Panelist · Of Counsel, HLA

Dual Credential

Pharmacist-Attorney

Nationally recognized pharmacist-attorney - the rare practitioner credentialed in both pharmacy and law.

USPTO

Registered Patent Attorney

Registered to practice before the U.S. Patent and Trademark Office on pharmaceutical IP matters.

Hofstra Law

Adjunct Faculty

Teaches Food, Drug & Cosmetic Law at Hofstra University's Maurice A. Deane School of Law.

200+ Publications

FDA, DEA & Pharmacy Law

One of the most published voices in the field, including on 503A and 503B compounding.

Panel Topics

What Martha will address

What next? Synopsis of FDA's Pharmacy Compounding Advisory Committee (PCAC) peptide meetings

Green or red, pharmaceutical grade vs RUO - why API peptide source matters?

Board of Pharmacy 503A enforcement trends and what to expect in 2027

FDA's Aggressive Warning Letter campaigns for GLPs and implications for peptide marketing

Speak with Counsel

Facing a peptide or compounding issue now

If you are dealing with an FDA inspection, a Form 483, a Warning Letter, a state board proceeding, or a question about peptide sourcing and 503A compliance, you do not need to wait for the panel. Dr. Rumore and the Health Law Alliance compounding team advise pharmacies and outsourcing facilities nationwide.

Available 24/7 · Speak with an attorney, not a call center

(800) 345 - 4125

Or send the form and our team responds within one business day

Request a confidential consultation

Free, confidential case review. Attorney-client privilege applies from first contact.